Hyperfine, Inc. the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced the appointments of Rob Fasciano, PhD, as Chief Regulatory and Quality Officer, and Rafael O’Halloran, PhD, as Vice President of Technology. These leadership additions were instrumental in the development of the recently FDA-cleared Optive AI™ software and the new, next-generation Swoop® scanner. Their work will greatly aid the rollout of this new technology globally and the development of future software enhancements.

Rob Fasciano, PhD, joined Hyperfine as Chief Regulatory and Quality Officer, bringing over 25 years of leadership experience in regulatory affairs, quality systems, and R&D in the medical device and diagnostics space. He has held senior roles at Abiomed, Johnson & Johnson, Orchestra BioMed, and Impulse Dynamics. Dr. Fasciano earned a PhD from Johns Hopkins University, an MBA from Purdue University, an MS from Boston University, and a BA from Dartmouth College.

Rafael O’Halloran, PhD, was appointed as Vice President of Technology. Dr. O’Halloran has over two decades of experience in MRI physics focused on innovation in sequence development and image reconstruction. Most recently, he led the development of the AI-driven image pipeline at Hyperfine. Previously, he served as an Assistant Professor of Radiology at the Mount Sinai School of Medicine, focusing on the use of diffusion-weighted imaging in neuromodulation and the study of psychiatric disorders. Prior to his work at Mount Sinai, he was a research associate at Stanford University. Dr. O’Halloran holds a PhD in medical physics from the University of Wisconsin-Madison and a BS in physics from Louisiana State University.

“These appointments further strengthen our capabilities as we scale the commercialization of our next-generation Swoop® system with Optive AI™ software,” said Maria Sainz, President and Chief Executive Officer of Hyperfine. “Technology innovation is at the core of our mission and central to accelerating global adoption of the Swoop® system. Raf has been instrumental in elevating our imaging performance to the standard we deliver today. Rob joins at a pivotal time as we translate that innovation into globally cleared, commercially scalable products. I’m thrilled to have such talented and experienced leaders on the Hyperfine team as we continue to advance our mission and extend our reach to transform brain health.”

Source: businesswire.com